Mizuho Markets Americas LLC Purchases 1,307,531 Shares of CVS Health Co. (NYSE:CVS)

Mizuho Markets Americas LLC raised its holdings in shares of CVS Health Co. (NYSE:CVS) by 1,470.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,396,464 shares of the pharmacy operator’s stock after purchasing an additional 1,307,531 shares during the period. CVS Health accounts for about 1.8% of Mizuho Markets Americas LLC’s portfolio, making the stock its 14th largest position. Mizuho Markets Americas LLC owned 0.11% of CVS Health worth $87,810,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CVS. Assetmark Inc. raised its position in shares of CVS Health by 9.7% in the 3rd quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator’s stock worth $25,781,000 after acquiring an additional 36,132 shares in the last quarter. Cullinan Associates Inc. raised its holdings in CVS Health by 43.8% in the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock worth $7,125,000 after purchasing an additional 37,395 shares in the last quarter. Deerfield Management Company L.P. Series C bought a new stake in shares of CVS Health in the 2nd quarter valued at about $57,584,000. Oppenheimer Asset Management Inc. grew its position in shares of CVS Health by 5.7% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 448,323 shares of the pharmacy operator’s stock worth $28,191,000 after buying an additional 24,285 shares during the last quarter. Finally, CX Institutional raised its stake in shares of CVS Health by 698.0% during the 3rd quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after acquiring an additional 65,259 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of several analyst reports. Barclays cut their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Wells Fargo & Company dropped their target price on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Monday, November 4th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Finally, Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $72.44.

CVS Health Price Performance

CVS Health stock opened at $53.19 on Friday. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The firm has a market capitalization of $66.93 billion, a price-to-earnings ratio of 13.50, a PEG ratio of 0.93 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a fifty day simple moving average of $59.23 and a 200-day simple moving average of $58.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the business posted $2.21 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts anticipate that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.